These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diphenylhydantoin in children. Pharmacology and efficacy. Borofsky LG; Louis S; Kutt H Neurology; 1973 Sep; 23(9):967-72. PubMed ID: 4737688 [No Abstract] [Full Text] [Related]
3. Clinical implications of certain aspects of diphenylhydantoin metabolism. Bochner F; Hooper W; Tyrer J; Eadie M Proc Aust Assoc Neurol; 1973; 9():171-8. PubMed ID: 4719398 [No Abstract] [Full Text] [Related]
4. Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy. Olesen OV; Jensen ON Dan Med Bull; 1969 May; 16(5):154-8. PubMed ID: 4392189 [No Abstract] [Full Text] [Related]
5. Diphenylhydantoin as an anticonvulsant: protein binding and fluctuation of the serum and cerebrospinal fluid levels in forty mentally subnormal epileptics. Viukari NM; Tammisto P J Ment Defic Res; 1969 Dec; 13(4):235-44. PubMed ID: 4983146 [No Abstract] [Full Text] [Related]
6. [Phenytoin--blood levels and clinical aspects]. Strandfjord RE; Johannessen SI Tidsskr Nor Laegeforen; 1973 Feb; 93(6):395-8. PubMed ID: 4698026 [No Abstract] [Full Text] [Related]
7. A method for shifting from oral to intramuscular diphenylhydantoin administration. Wilder BJ; Serrano EE; Ramsey E; Buchanan RA Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662 [No Abstract] [Full Text] [Related]
8. [The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)]. Remmer H; Hirschmann J; Greiner I Dtsch Med Wochenschr; 1969 Jun; 94(24):1265-72. PubMed ID: 5771073 [No Abstract] [Full Text] [Related]
9. [Determination of diphenylhydantoin (DFH) in plasma in patients with epilepsy]. Borgå O; Lund L; Sjöqvist F Lakartidningen; 1969 Oct; 66():Suppl 3:89-98. PubMed ID: 5383812 [No Abstract] [Full Text] [Related]
10. Variations of serum diphenylhydantoin concentrations in epileptic out-patients. Vapaatalo H; Lehtinen L Eur Neurol; 1971; 5(5):303-10. PubMed ID: 5133553 [No Abstract] [Full Text] [Related]
11. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings]. Denegri M; Luciano L Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027 [No Abstract] [Full Text] [Related]
16. Diphenylhydantoin metabolism in uremia. Letteri JM; Mellk H; Louis S; Kutt H; Durante P; Glazko A N Engl J Med; 1971 Sep; 285(12):648-52. PubMed ID: 5563477 [No Abstract] [Full Text] [Related]
17. Serum protein binding of diphenylhydantoin in healthy man. Lecchini S; Gatti G; Caravaggi M; De Bernardi M; Calzetti S; Visintini D; Frigo GM Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1459-62. PubMed ID: 607956 [No Abstract] [Full Text] [Related]
18. Plasma albumin concentration and diphenylhydantoin binding in man. Porter RJ; Layzer RB Arch Neurol; 1975 May; 32(5):298-303. PubMed ID: 237499 [TBL] [Abstract][Full Text] [Related]
19. Physiological and physicochemical bases of drug interactions in man. Dayton PG; Perel JM Ann N Y Acad Sci; 1971 Jul; 179():67-87. PubMed ID: 4105795 [No Abstract] [Full Text] [Related]
20. Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin. Mamada K; Kasuya Y; Baba S Drug Metab Dispos; 1986; 14(4):509-11. PubMed ID: 2874002 [No Abstract] [Full Text] [Related] [Next] [New Search]